These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 15801256)
1. Antihistamines and driving ability: evidence from on-the-road driving studies during normal traffic. Roberts DJ Ann Allergy Asthma Immunol; 2005 Mar; 94(3):407-9; author reply 409-10. PubMed ID: 15801256 [No Abstract] [Full Text] [Related]
2. Safety of ebastine. Cadahía A; Cardona V; Guilarte M; Muñoz-Cano R Ann Allergy Asthma Immunol; 2005 Mar; 94(3):407. PubMed ID: 15801255 [No Abstract] [Full Text] [Related]
3. Antihistamines and driving ability: evidence from on-the-road driving studies during normal traffic. Verster JC; Volkerts ER Ann Allergy Asthma Immunol; 2004 Mar; 92(3):294-303; quiz 303-5, 355. PubMed ID: 15049392 [TBL] [Abstract][Full Text] [Related]
4. [Antihistamines. How safe are they?]. MMW Fortschr Med; 2002 Sep; 144(37):53. PubMed ID: 12380340 [No Abstract] [Full Text] [Related]
5. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects. Hey JA; del Prado M; Sherwood J; Kreutner W; Egan RW Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304 [TBL] [Abstract][Full Text] [Related]
6. Terfenadine, astemizole, and ebastine produce QTc interval prolongation in an experimental model predictive of adverse clinical ECG effects. Hey JA; del Prado M; Egan RW; Kreutner W Ann Allergy Asthma Immunol; 1996 May; 76(5):476. PubMed ID: 8630724 [No Abstract] [Full Text] [Related]
7. [Cardiac arrest following treatment with non-cardiologic QT-interval-increasing medications]. Al-Amood S; Elming H Ugeskr Laeger; 2005 May; 167(18):1966-8. PubMed ID: 15929273 [No Abstract] [Full Text] [Related]
8. Cardiovascular safety of second-generation antihistamines. Barbey JT; Anderson M; Ciprandi G; Frew AJ; Morad M; Priori SG; Ongini E; Affrime MB Am J Rhinol; 1999; 13(3):235-43. PubMed ID: 10392245 [TBL] [Abstract][Full Text] [Related]
9. Cardiotoxicity of second-generation antihistamines. Roberts DJ Drugs; 1999 Jun; 57(6):1033-4. PubMed ID: 10400411 [No Abstract] [Full Text] [Related]
10. Assessing the cardiac safety of ebastine. Prologue. Roberts DJ Drug Saf; 1999; 21 Suppl 1():1-3. PubMed ID: 10597862 [No Abstract] [Full Text] [Related]
11. [Terfenadine and automobile driving. A placebo controlled double-blind study of the effect of different antihistamines on driving behavior]. Bieber T; Ring J Med Klin (Munich); 1987 Oct; 82(20):683-6. PubMed ID: 2891022 [No Abstract] [Full Text] [Related]
17. [Experimental psychology studies of a new antihistaminic. Various achievement functions with reference to driving ability]. Biehl B Med Welt; 1969 Mar; 12():652-7. PubMed ID: 4388720 [No Abstract] [Full Text] [Related]
18. Drug interactions associated with terfenadine and related nonsedating antihistamines. Zechnich AD; Haxby DG West J Med; 1996 Jan; 164(1):68-9. PubMed ID: 8779212 [No Abstract] [Full Text] [Related]
19. Antihistamines in drivers, aircrew and occupations of risk. Jáuregui I; Ferrer M; Montoro J; Dávila I; Bartra J; del Cuvillo A; Mullol J; Sastre J; Valero A J Investig Allergol Clin Immunol; 2013; 23 Suppl 1():27-34. PubMed ID: 24672892 [TBL] [Abstract][Full Text] [Related]
20. Ebastine in perennial allergic rhinitis. Picado Vallés C; Cadahia García A; Cisteró Bahima A; Cano Cantudo L; Sanz Amaro A; Zayas Sanza JM Ann Allergy; 1991 Dec; 67(6):615-8. PubMed ID: 1684273 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]